Shots: The approval is based on P-lll COMPACT pivotal study and OLE study assessing Haegarda (C1 Esterase Inhibitor, SC) vs PBO in patients aged ≤17yrs. with symptomatic HAE. Results […]readmore
Tags : HAE
Shots: Approval is based on four clinical studies including P-III HELP (Hereditary Angioedema Long-term Prophylaxis) study (N=125) for 26 wks, administering Takhzyro 300mg Q2W, Q4W and 150 mg Q4W HELP […]readmore